Neuroprotection

Apr 23, 2018

Peptron Expands Exclusive License with NIH to Support Developing SR-exenatide to Treat Neurodegenerative Diseases

Mar 15, 2018

Global Neuroprotection Market to Reach Over US$ 47,000.0 Mn by 2025; Constantly Rising Cases of Neurodegenerative Disorders to Fuel Market Growth, Observes Transparency Market Research

Feb 08, 2018

Global Neuroprotection Report 2018: Drugs, Markets and Companies Analysis, Estimates & Forecasts 2017-2027

Jan 31, 2018

A new publication confirms AZTherapies's innovative drug combination approach to address the neuroinflammation response via neuro-immunology and amyloid beta accumulation associated with neurodegeneration and Alzheimer's disease.

Jan 04, 2018

Mercaptor Discoveries Featured in Sports Illustrated

Nov 07, 2017

Neuroprotection Drugs, Markets and Companies Report: 500 Products & 141 Company Profiles

Oct 31, 2017

AZTherapies, Inc. appoints Karen Reeves, MD as President and Chief Medical Officer

Sep 15, 2017

Biohaven And Alzheimer's Disease Cooperative Study (ADCS) Announce Phase 2 Clinical Trial Collaboration Evaluating Glutamate Modulating Agent Trigriluzole In Patients With Mild-To-Moderate Alzheimer's Disease